PharmacoEconomics & Outcomes News 466 - 20 Nov 2004

■ A new report from analysts at Wood Mackenziesuggests that growth in the US pharmaceuticalsmarket through to 2008 is expected to drop below10%. The firm says that several key patent expiries, USMedicare reform, and a relatively slim research anddevelopment pipeline are responsible for theslowdown. Nevertheless, the US is still expected tooutpace the global market.US market growth to drop below 10%. Pharma Times : [2 pages], 9 Nov 2004.Available from: URL: http://www.pharmatimes.com 800967353

1

PharmacoEconomics & Outcomes News 20 Nov 2004 No. 4661173-5503/10/0466-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved